The ENGAGE-2 study: Engaging self-regulation targets to understand the mechanisms of behavior change and improve mood and weight outcomes in a randomized controlled trial (Phase 2)

Despite evidence for effective integrated behavior therapy for treating comorbid obesity and depression, treatment response is highly variable and the underlying neurobiological mechanisms remain unknown. This hampers efforts to identify mechanistic targets in order to optimize treatment precision and potency. Funded within the NIH Science of Behavior Change (SOBC) Research Network, the 2-phased ENGAGE research project applies an experimental precision medicine approach to address this gap. The Phase 1 study focused on demonstrating technical feasibility, target engagement and potential neural mechanisms of responses to an integrated behavior therapy.

Source: Contemporary Clinical Trials - June 30, 2020 Category: Radiology Authors: Nan Lv, Olusola A. Ajilore, Corina R. Ronneberg, Elizabeth M. Venditti, Mark B. Snowden, Philip W. Lavori, Lan Xiao, Andrea N. Goldstein-Piekarski, Joseph Wielgosz, Nancy E. Wittels, Amruta Barve, Aashutos S. Patel, Tessa L. Eckley, Patrick Stetz, Ben S. Source Type: research